HÉCTOR JOSÉ
BUENO ZAMORA

Profesor asociado

Foto de HÉCTOR JOSÉ

Foto de Duke Clinical Research Institute

Duke Clinical Research Institute

Durham, Estados Unidos

Publicaciones en colaboración con investigadores/as de Duke Clinical Research Institute (5)

2023

External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registry
International Journal of Cardiology, Vol. 370, pp. 51-57

2020

Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis
Thrombosis Research, Vol. 195, pp. 128-135

2017

Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
The Lancet, Vol. 389, Núm. 10081, pp. 1799-1808

2007

Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: Benefit and harm in different age subgroups
Heart, Vol. 93, Núm. 4, pp. 450-455

2006

Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromes
European Heart Journal, Vol. 27, Núm. 24, pp. 2956-2961